Anti-Human CX3CR1 Antibody (SAA2443) from ProteoGenix; catalogue ARO-A22896; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The Anti-Human CX3CR1 Antibody (SAA2443) is a highly specific and reliable tool for studying the CX3CR1 protein in human samples. This antibody is a valuable addition to any research targeting the CX3CR1 protein, as it has been extensively validated for use in various experimental procedures.
The CX3CR1 protein, also known as fractalkine receptor, is a G-protein-coupled receptor that is expressed on the surface of various immune cells, including monocytes, macrophages, and T cells. It plays a crucial role in regulating immune responses and inflammation by binding to its ligand, CX3CL1. Dysregulation of the CX3CR1 protein has been linked to various diseases, making it an important target for research.
The Anti-Human CX3CR1 Antibody (SAA2443) is specifically designed for use in immunohistochemistry (IHC), immunofluorescence (IF), and flow cytometry (FC) experiments. Its high specificity and sensitivity make it an ideal tool for detecting and quantifying CX3CR1 protein expression in human tissue samples. This antibody can also be used for Western blotting (WB) and ELISA experiments, providing researchers with a comprehensive understanding of CX3CR1 protein expression and function.
The Anti-Human CX3CR1 Antibody (SAA2443) has been successfully used in various research studies, including investigations into the role of CX3CR1 in inflammatory diseases, such as atherosclerosis, rheumatoid arthritis, and multiple sclerosis. It has also been used to study the involvement of CX3CR1 in cancer progression and metastasis. Additionally, this antibody has been used to examine the expression of CX3CR1 in different human tissues, providing valuable insights into its tissue-specific functions.
In conclusion, the Anti-Human CX3CR1 Antibody (SAA2443) is a highly specific and reliable tool for studying the CX3CR1 protein in human samples. Its extensive validation, along with its various applications and successful use in multiple experimental studies, makes it a valuable asset for any research targeting the CX3CR1 protein. Order now and advance your research on this important immune regulator.
ProteoGenix catalogue number ARO-A22896. For research use only.
Target: CX3C chemokine receptor 1, C-X3-C CKR-1, CX3CR1, Beta chemokine receptor-like 1, CMK-BRL-1, CMK-BRL1, Fractalkine receptor, G-protein coupled receptor 13, V28, CX3CR1, CMKBRL1, GPR13; Clonality: Monoclonal Antibody; Reactivity: Human; Applications: Block, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | Block |
|---|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
